<DOC>
	<DOCNO>NCT01363765</DOCNO>
	<brief_summary>Diagnosis tuberculosis ( TB ) challenge sputum smear , rapid inexpensive test , often fail detect disease , around 20 30 % case . Culture sputum yield correct diagnosis 90 % case , result available 4 8 week , depend method . A new test ( Xpert MTB/Rif ) base rapid technique , name polymerase chain reaction ( PCR ) , detect TB le 2 hour 95 % case , addition identification case resistant certain drug use treat TB . The test expensive , several study demonstrate accuracy , since step automatize , saving expect human resource work . The aim study ( 1 ) evaluate tool substitute test sputum smear routine condition ; ( 2 ) evaluate cost-effective , mean effectiveness test may outweigh extra cost , ( 3 ) evaluate acceptability test among patient health care worker .</brief_summary>
	<brief_title>Xpert MTB/Rif , New Tool Diagnosis Pulmonary Tuberculosis Two Municipalities Brazil</brief_title>
	<detailed_description>The main study consist group-randomized pragmatic trial follow stepped-wedge design . The GeneXpert machine instal laboratory basic health unit Rio de Janeiro Manaus , two city high burden disease Brazil . Doctors prescribe routine test clinic . When sputum specimens arrive laboratory , instead perform smear , Xpert MTB/Rif perform intervention period . If positive , sputum smear also perform . The intervention period precede observation period routine kept unchanged , i.e. , smear perform . The observation period serve comparator ( control ) . The investigator see many case detect intervention period , particular , many smear-negative case detect , compare observation period . A total 35,000 specimen expect test new technology 14 laboratory . Laboratories , individual , randomize .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<criteria>laboratory subject randomize . All laboratory start smear , indicated randomization , switch Xpert MTB/Rif . There inclusion exclusion criterion labs . Sputum specimens nondiagnostic ( follow ) patient , second sample diagnostic test , insufficient volume/visible blood specimen exclude Xpert testing .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>diagnosis</keyword>
	<keyword>polymerase chain reaction</keyword>
	<keyword>sputum smear</keyword>
	<keyword>stepped-wedge design</keyword>
	<keyword>cost-effectiveness</keyword>
	<keyword>Xpert MTB/Rif</keyword>
</DOC>